Maravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of $0.03, $0.01 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $79.03 million versus the consensus estimate of $80.86 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.